News and Press Releases
Steritas’ Pediatric Glucocorticoid Toxicity Index applied by Alder Hey Children’s NHS Foundation Trust and Liverpool Clinical Trials Centre in clinical trial to assess steroid-toxicity in children with juvenile idiopathic arthritis
Study will allow researchers to assess the outcomes of intravenous and oral glucocorticoid protocols in children 24 September 2024 -- Massachusetts, US -- Steritas LLC., a company dedicated to enhancing...
Category: Biotechnology, Clinical Trials, Pharmaceutical
Posted: September 24, 2024
Duke Street Bio Granted Approval by European Medicines Agency to Launch Next-Generation PARP1-Selective Inhibitor Trial
24 September 2024 -- London, UK -- Duke Street Bio Ltd, a precision medicine biotech developing next generation small molecule cancer therapies, is pleased to announce that the European Medicines...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: September 24, 2024
Tracey Marantal Joins Worldwide Clinical Trials as President, Oncology Business Unit
Proven clinical operations leader joins global CRO to lead high-performing therapeutic team and drive strategy for growing oncology portfolio 24 September 2024 -- North Carolina, US -- Tracey Marantal has...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: September 24, 2024
600 Park Offices Drive Suite 200 Research Triangle Park, NC 27709 USA
ETIHAD CARGO CELEBRATES 20 YEARS OF SUCCESSFUL OPERATIONS IN INDIA
Etihad Cargo is celebrating 20 years of operations in India, reflecting its long-term commitment to the market. The airline has significantly expanded its presence, offering belly hold capacity via nonstop...
Category: Logistics
Posted: September 24, 2024
RHYTHM AI announces FDA clearance of the commercial release version of STAR Apollo Mapping System
First-in-human cases successfully completed using this new system at Baptist Health, Jacksonville, Florida 23 September 2024, – London, UK – RHYTHM AI Ltd (“RHYTHM AI” or “the Company”), a UK...
Category: Biotechnology, Clinical Trials
Posted: September 23, 2024
Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old
Recommendation based on a phase 3 study showing a significantly greater proportion of children on Dupixent achieved histological remission, compared to placebo, consistent with improvements seen in adults and adolescents...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: September 20, 2024
The Charter Building, Vine Street, Uxbridge, Middlesex, United Kingdom, UB8 1JG
DARZALEX® (daratumumab)-based quadruplet regimen receives positive CHMP opinion for transplant-eligible patients with newly diagnosed multiple myeloma
Recommendation supported by findings from quadruplet therapy PERSEUS study with daratumumab subcutaneous (SC) formulation in the frontline setting Findings showed 60 percent reduction in risk of disease progression or death...
Category: Biotechnology, Clinical Trials, Drug Discovery, Pharmaceutical
Posted: September 20, 2024
Janssen-Cilag Limited 50-100 Holmers Farm Way High Wycombe Buckinghamshire HP12 4EG
Professor V. A. Bumelis opens the Lithuanian Museum of Biotechnology
20 September 2024 – Savaitiskes, Lithuania –The 40th anniversary of the Lithuanian biopharmaceutical industry and science was marked on Monday with the opening of the Lithuanian Biotechnology Museum in the...
Category: Biotechnology, Other
Posted: September 20, 2024
Tiziana Life Sciences Announces $4 Million Grant Awarded by National Institutes of Health to Study Anti-CD3 in Alzheimer’s Disease
19 September 2024 -- New York, US -- Tiziana Life Sciences, Ltd, a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3...
Category: Biotechnology, Clinical Trials, Pharmaceutical
Posted: September 19, 2024
Tiziana Life Sciences 14/15 Conduit Street London W1S 2XJ United Kingdom
AGREEMENT WITH RECURSION PHARMACEUTICALS
New pharma agreement for Parsortix CTC analysis 19 September 2024 -- Guilford, UK -- ANGLE plc, a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use...
Category: Biotechnology, Drug Discovery, Pharmaceutical
Posted: September 19, 2024
Headlands Research to Open New Clinical Research Site in El Paso, Texas
Office will be led by Dr. Ryan Casey, a family medicine clinician experienced in treating underserved communities along the US southern border region 19 September 2024 -- California, US --...
Category: Clinical Trials, Drug Discovery
Posted: September 19, 2024
U.S. grants Vidac Pharma patent offering broad protection of mode of action underlying its oncology drug candidates
19 September 2024 -- London, UK -- Vidac Pharma Holdings Plc, a clinical-stage oncology biopharmaceutical company pioneering a novel class of cancer treatments, today announces that the United States Patent and...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: September 19, 2024
Vidac Pharma Holding PLC, Dr. Max Herzberg, 20-22 Wenlock Road, London N1 7GU, United Kingdom
ETIHAD CARGO AND SF AIRLINES TO STRENGTHEN UAE-CHINA TRADE WITH JOINT VENTURE COMMITMENT
Etihad Cargo and SF Airlines have announced a project to establish a first-of-its-kind joint venture with the aim of promoting economic and trade cooperation and enhancing global logistics and connectivity....
Category: Logistics
Posted: September 19, 2024
PrecisionLife and Metrodora Institute share first insights with ME/CFS, Long COVID participants in MetX research study
MetX funded by $1M grant from Metrodora Foundation to accelerate research for complex multisystem disorders 18 September 2024 -- Utah, US, and Oxford, UK -- PrecisionLife, a leading clinical-stage precision...
Category: Biotechnology, Clinical Trials, Drug Discovery, Pharmaceutical
Posted: September 18, 2024
PlaqueTec and RxCelerate collaborate on early phase drug discovery for coronary artery disease
Project evaluated small molecules against novel target in coronary artery disease discovered by PlaqueTec Bespoke cell-based assay developed by RxCelerate to test small molecules predicted to bind candidate target. 18...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: September 18, 2024
